Please login to the form below

Not currently logged in
Email:
Password:

Merck expands in emerging markets

Merck has acquired a supplier to the biopharma industry in China as it opens a new technology centre in India

Merck has announced the acquisition of Beijing Skywing Technology, a supplier of cell-culture media products, technical services and bioreactors for the Chinese biopharmaceutical industry.

The deal, worth around €14m, will see German-based Merck take 100 per cent share of the company adding to its presence in China where it currently employs 600 people. The company said it expects the country's biopharmaceutical market to grow by 20 per cent over the next few years.

"The acquisition allows Merck to immediately establish a direct presence in this market segment in China with access to an attractive and innovative cell-culture media portfolio, close relationships to local customers, a skilled management team and a high-quality facility," said Burghard Freiberg, head of the business field pharma chemicals solutions of the Merck Millipore division.

Dr Matthias Bucerius, head of sales Asia, pharma chemicals solutions of the Merck Millipore division, said: "Beijing Skywing Technology is one of the leading players in the cell-culture media market in China with very close business relationships to vaccine manufacturers and an excellent reputation in the local biotech industry."

In addition to this acquisition, Merck also opened a new technology centre in Mumbai, India focusing on research services in both pharmaceuticals and biotechnology. The centre comprises eight laboratories, with the discovery of new biological and chemical entities for use in drug development a key area of research.

Speaking on the opening of the centre, Klaus Bischoff, head of laboratory solutions business unit, Merck Millipore, said: "Supported by over 300 years of experience, the new application and technology centre will be an ideal platform to showcase Merck's capabilities in the high growth fields of biopharmaceutical process solutions and laboratory essentials as well as pigments and cosmetics for our customers in India."

5th January 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics